Armata Pharmaceuticals (ARMP) Cash from Investing Activities Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 38.24% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -22.09% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 30.54% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | 68.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.47% |
| Dec 31, 2025 | -28.35% |
| Sep 30, 2025 | 42.81% |
| Jun 30, 2025 | 49.19% |
| Mar 31, 2025 | 25.14% |
| Dec 31, 2024 | 32.72% |
| Sep 30, 2024 | 16.40% |
| Jun 30, 2024 | -91.01% |
| Mar 31, 2024 | 5.69% |
| Dec 31, 2023 | -86.91% |
| Sep 30, 2023 | -251.31% |
| Jun 30, 2023 | 6.66% |
| Mar 31, 2023 | -168.36% |
| Dec 31, 2022 | 84.88% |
| Sep 30, 2022 | -179.81% |
| Jun 30, 2022 | -33.78% |
| Mar 31, 2022 | -18.45% |
| Dec 31, 2021 | 24.75% |
| Sep 30, 2021 | -275.41% |
| Dec 31, 2020 | -172.94% |
| Sep 30, 2020 | -34.89% |
| Jun 30, 2020 | -414.89% |
| Mar 31, 2020 | -175.01% |
| Dec 31, 2019 | 96.08% |
| Sep 30, 2019 | 61.87% |
| Jun 30, 2019 | 192.62% |
| Mar 31, 2019 | -8.23% |
| Dec 31, 2018 | -120.36% |
| Sep 30, 2018 | 54.40% |
| Dec 31, 2017 | -53.26% |
| Sep 30, 2017 | 37.78% |
| Jun 30, 2017 | 86.60% |
| Mar 31, 2017 | 72.05% |
| Dec 31, 2016 | -37.51% |
| Sep 30, 2016 | 3.23% |
| Jun 30, 2016 | -24.36% |